Acute Beneficial Effects of a Rho-Kinase Inhibitor, Fasudil in Patients With Pulmonary Hypertension Due to Left Heart Disease

被引:0
|
作者
Ishiyama, Masaki
Fujimoto, Naoki
Sato, Toru
Omori, Taku
Moriwaki, Keishi
Sugiura, Emiyo
Ogihara, Yoshito
Nakamori, Shiro
Kurita, Tairo
Dohi, Kaoru
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A13710
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Cyclophilin a Mediates Pulmonary Vascular Remodeling by Rho-Kinase Activation in Patients With Pulmonary Hypertension
    Satoh, Kimio
    Fukumoto, Yoshihiro
    Sugimura, Koichiro
    Tatebe, Shunsuke
    Miura, Yutaka
    Miyamichi, Saori
    Nakamura, Kazufumi
    Nigro, Patrizia
    Berk, Bradford C.
    Shimokawa, Hiroaki
    CIRCULATION, 2010, 122 (21)
  • [42] Pulmonary hypertension due to left heart disease
    Vachiery, Jean-Luc
    Tedford, Ryan J.
    Rosenkranz, Stephan
    Palazzini, Massimiliano
    Lang, Irene
    Guazzi, Marco
    Coghlan, Gerry
    Chazova, Irina
    De Marco, Teresa
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [43] Pulmonary Hypertension Due to Left Heart Disease
    Al-Omary, Mohammed S.
    Sugito, Stuart
    Boyle, Andrew J.
    Sverdlov, Aaron L.
    Collins, Nicholas J.
    HYPERTENSION, 2020, 75 (06) : 1397 - 1408
  • [44] Pulmonary Hypertension due to Left Heart Disease
    Fukumoto, Yoshihiro
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S124 - S124
  • [45] Pulmonary Hypertension Due to Left Heart Disease
    Guazzi, Marco
    Borlaug, Barry A.
    CIRCULATION, 2012, 126 (08) : 975 - 990
  • [46] Pulmonary Hypertension Due to Left Heart Disease
    Gerges, Mario
    Gerges, Christian
    Naeije, Robert
    Lang, Irene M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 662 - 676
  • [47] Pulmonary hypertension due to left heart disease
    Berthelot, Emmanuelle
    Bailly, Minh Tam
    El Hatimi, Safwane
    Robard, Ingrid
    Rezgui, Hatem
    Bouchachi, Amir
    Montani, David
    Sitbon, Olivier
    Chemla, Denis
    Assayag, Patrick
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (6-7) : 420 - 431
  • [48] Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase
    Fagan, KA
    Oka, M
    Bauer, NR
    Gebb, SA
    Ivy, DD
    Morris, KG
    McMurtry, IF
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (04) : L656 - L664
  • [49] Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension
    Sun, Xing-Zhen
    Li, Shu-Yan
    Tian, Xiang-Yang
    Hong, Ze
    Li, Jia-Xin
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2019, 71 (01) : 3 - 8
  • [50] The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Review and Meta-Analysis
    Abedi, Farshad
    Omidkhoda, Navid
    Arasteh, Omid
    Ghavami, Vahid
    Hosseinzadeh, Hossein
    DRUG RESEARCH, 2023, 73 (01) : 5 - 16